Re-registration: AST/ALT =<  x ULN
AST/ALT ?.  ULN
Serum AST and ALT ?  X ULN
AST or ALT > .  ULN. For patients with liver metastasis AST or ALT >   ULN.
Serum ALT and AST levels ?. x ULN
AST and ALT are each ?  the ULN;
Chronic hepatitis B as defined below or elevated AST, ALT >  ULN
AST and ALT ?  x ULN
AST and ALT must be ? . x ULN for the lab.
Serum AST and/or ALT <  x institutional ULN.
ALT and AST ?   ULN
ALT and AST ? . ULN
AST or ALT > .  ULN. For patients with liver metastasis AST or ALT >   ULN
AST or ALT > . x ULN; for patients with liver metastasis AST or ALT >  x ULN
ALT and AST ?. x ULN
COHORT : ENDOMETRIAL CANCER: AST and ALT levels =<  X ULN
Serum ALT/AST ? . x ULN
AST and ALT with hepatic metastasis =<  x ULN
AST/ ALT ? .x institutional ULN
AST and ALT <. x ULN
Cabazitaxel: AST =< . x ULN
AST and ALT>xULN
Serum ALT/AST ? . ULN
Grade  AST or ALT elevation
AST and ALT ?  x ULN
AST and ALT < . x ULN
AST or ALT > . x ULN
Serum ALT, AST ?   ULN
PHASE II: AST and ALT <  x ULN
AST and ALT < x ULN
ALT and AST ? . ULN
Inotuzumab within  days and must have ALT, AST and bilirubin < ULN.
ARM C COHORT : AST and ALT =<  x ULN
AST/ALT =< X ULN; -Bilirubin =<. X ULN, unless resulting from hemolysis
AST < . x ULN
AST and ALT ? . x ULN
AST and ALT <. x ULN
Chemistry: ALT/AST ? . x ULN, TBili ?. x ULN, and Cr <  mg/dL
Aspartate aminotransferase (AST) must be =<  x ULN for the lab within  days before randomization;\r\n* Note: if alanine aminotransferase (ALT) is performed instead of AST (per institution's standard practice), the ALT value must be =<  x ULN; if both were performed, the AST must also be =<  x ULN; if AST and/or ALT is >= ULN but =<  x ULN, serologic testing for hepatitis B and C must be performed and results for viral infection must be negative
AST or ALT less than or equal to . X institutional ULN
AST/ALT < . x ULN
AST/ALT =< . x ULN
ALT or AST < x ULN
Subjects who have BOTH bilirubin greater than ULN and AST/ALT greater than . x ULN are not eligible
AST <  ULN
MF PATIENTS: ALT/AST =< . x ULN
Patients with hepatocellular carcinoma may be eligible provided they have AST and ALT that are ? . x ULN.
AST =< . x ULN or ALT =< . x ULN is acceptable if liver has tumor involvement; (Note, if both AST and ALT are done, both must be =< . x ULN)
ALT and AST ? x ULN or ? x ULN if known hepatic metastases.
AST and/or ALT > x ULN
ALT and AST less than or equal to  x ULN
AST and ALT ? . x ULN
AST and ALT ?.  institutional ULN. Patients enrolled in an expansion stage may have ALT and AST <  institutional ULN if the patient has hepatic metastases.
Serum ALT/AST ? . x ULN
AST >  x ULN
AST, ALT must be < x ULN.
AST or ALT >  x ULN
AST/ALT: ? . x ULN
AST or ALT ?. x ULN
AST/ALT ? .  ULN
ALT and AST ? . x ULN (subjects with known liver metastases may have AST and ALT ? . x ULN)
COHORT B: AST/ALT =< . x ULN
AST and ALT < . x ULN
Subjects who have both bilirubin > ULN and AST/ALT > ULN
Concomitant elevations in bilirubin and AST/ALT above . x ULN not permitted
AST and ALT ?  x ULN
AST/ALT < . x ULN
AST/ALT < . x ULN
PRIOR TO POST-TRANSPLANT IMMUNOTHERAPY: AST/ALT < . x ULN
ALT or AST > . x ULN at screening
AST and ALT must be ?  x Upper Limit of Normal (ULN) if this elevation is solely due to ASM/MCL, otherwise AST, ALT must be ? . x ULN
Serum AST and ALT ?  x ULN;
AST and ALT . ULN with the following exception: Patients with liver involvement: AST and/or ALT  ULN
Serum AST or ALT ? . x ULN
Serum ALT/AST <. ULN
Patients with AST/ALT > ULN must have negative hepatitis studies
AST or ALT > .  ULN. For patients with liver metastasis, AST or ALT >   ULN
ALT and AST ? . x ULN
AST and ALT ? . X ULN
ALT and AST > .ULN. For patients with documented liver metastases, ALT and AST > ULN.
ALT and AST <  x ULN (unless attributed to leukemic involvement)
Serum Bilirubin ? ULN, AST and ALT ? ULN
AST and ALT ?  x ULN, except in patients with tumor involvement of the liver who must have AST and ALT ?  x ULN.
AST or ALT >  the ULN for the institution (>  ULN if due to hepatic involvement by tumor)
AST & ALT ? . x ULN
ALT and/or AST ?. X ULN
ALT and/or AST ?.X ULN
ALT and/or AST ?X ULN
ALT and/or AST ?X ULN
ALT or AST >  x ULN
AST and ALT =< . x ULN
AST and ALT < . x ULN
ALT and AST <.  ULN or, in patients with documented hepatic metastasis, ?.  ULN.
ALT and AST ? . x ULN within  days prior to registration
AST, and ALT > . x ULN
ALT and AST ? . ULN of institution's range
AST/ALT < . x ULN
AST ? . x ULN
